ARCHIVES

FDA Rejects Genentech Bid For Accelerated Approval For T-DM1. NCI Breaks Ground For Satellite Campus At Shady Grove

This article is from The Cancer Letter archive.

Vol. 36 No. 31 | September 3, 2010

Download PDF Visit The Full Archive

Related Articles

New Drug Approvals Point To Greater Role Of Randomization In Cancer Clinical Trials. European Standards Will Demand More Rigor.

February 24, 2006

Rall Says NTP Must Have New Positions To Spend Extra $23 Million On Testing More Chemicals

September 7, 1979

Guest Commentary: Donald Berry Finds Fundamental Flaws In Data Pooling Plan.

November 16, 2007

New Treatment For CML Could Be Model for Molecular Target-Based Therapeutics

December 10, 1999

Amgen Commits $1.5M To CDC Foundation For Education Program

May 29, 2009

Barnett Kramer Retires From NIH

January 7, 2011